+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Male Infertility Market by Treatment Type, Diagnosis Type, Cause Type, Sperm Defect Category, Age Group, End User - Global Forecast 2026-2032- Product Image
Male Infertility Market by Treatment Type, Diagnosis Type, Cause Type, Sperm Defect Category, Age Group, End User - Global Forecast 2026-2032- Product Image
Sale

Male Infertility Market by Treatment Type, Diagnosis Type, Cause Type, Sperm Defect Category, Age Group, End User - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904835
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Male Infertility Market is projected to reach USD 5.07 Billion in 2026. It is expected to continue growing at a CAGR of 6.45%, reaching USD 7.41 Billion by 2032.

Male infertility is a clinically significant and increasingly visible segment of reproductive health. The World Health Organization reports that infertility affects about 17.5% of adults globally, and male factors contribute to roughly half of infertility cases when combined male-female etiologies are included. This places semen analysis, hormonal evaluation, genetic testing, microsurgery, assisted reproductive technology, and lifestyle intervention at the center of a data-driven care pathway.

Demand is being shaped by delayed parenthood, rising awareness of sperm quality decline, higher use of in vitro fertilization and intracytoplasmic sperm injection, and improved access to specialist andrology services. For healthcare providers, diagnostics developers, fertility clinics, and investors, the opportunity depends on earlier diagnosis, evidence-based treatment selection, affordability, and patient-centered care that reduces stigma around male reproductive health.

Transformative Shifts in the Male Infertility Landscape

The male infertility landscape is shifting from late-stage fertility intervention to earlier, more personalized reproductive health management. The WHO Laboratory Manual for the Examination and Processing of Human Semen, 6th edition, has reinforced standardized testing, while clinicians increasingly combine semen parameters with endocrine, genetic, imaging, and lifestyle data to better identify treatable causes such as varicocele, hypogonadism, obstruction, infection, oxidative stress, and ejaculatory dysfunction.

At the same time, consumer health engagement is rising through at-home semen testing, tele-andrology, fertility preservation, and digital education. Regulatory scrutiny is also intensifying around laboratory quality, genetic data, embryo handling, and claims made by direct-to-consumer tests. The most competitive organizations are integrating clinical accuracy, transparent pricing, counseling, and coordinated care across urology and reproductive endocrinology.

Cumulative Impact of Artificial Intelligence on Male Infertility Care

Artificial intelligence is beginning to influence male infertility care through computer-assisted semen analysis, sperm morphology assessment, sperm selection research, workflow automation, predictive analytics, and patient triage. AI can help reduce observer variability in semen assessment, improve laboratory throughput, and support decision-making when combined with validated clinical inputs such as semen concentration, motility, morphology, DNA fragmentation, hormonal profiles, age, and prior reproductive history.

The cumulative impact will depend on clinical validation, bias testing, explainability, and compliance with medical device and data protection rules. AI should not replace clinical judgment, but it can improve consistency, support personalized treatment planning, and help fertility clinics identify which patients may benefit from lifestyle modification, medical therapy, microsurgery, IUI, IVF, or ICSI.

Key Regional Insights Across Male Infertility Markets

Asia-Pacific is gaining strategic importance because China and India combine large reproductive-age populations with rising fertility service capacity, while Japan, South Korea, and Australia bring advanced clinical infrastructure and strong demand linked to delayed parenthood and low birth rates. North America remains a high-value region due to established fertility clinics, CDC ART reporting in the United States, advanced genetic testing adoption, and growing employer fertility benefits, although insurance coverage remains uneven.

Europe benefits from mature ART governance, strong specialist networks, and structured oversight from national regulators such as the UK Human Fertilisation and Embryology Authority, while EU medical device and data regulations raise the bar for diagnostics and software. Latin America, led by Brazil and Mexico, is supported by private fertility care and cross-border affordability. The Middle East shows rising demand through premium IVF centers in GCC markets, while Africa remains underserved, with access gaps, infectious disease burden, and limited specialist capacity creating unmet need for male infertility diagnosis, semen analysis, and ART access.

Key Group Insights for Male Infertility Growth

ASEAN markets are becoming more relevant as Thailand, Malaysia, Singapore, Indonesia, Vietnam, and the Philippines expand fertility services at different levels of regulation and affordability. The GCC is positioned around premium clinical infrastructure, high private healthcare expenditure, and demand for culturally sensitive fertility care. The European Union offers regulatory harmonization, strong laboratory standards, and broad research capacity, making it attractive for compliant diagnostics, AI-enabled tools, and fertility preservation services.

BRICS countries combine large patient pools, expanding healthcare investment, and local manufacturing potential, but reimbursement and regulatory consistency vary. G7 economies lead in reproductive medicine research, quality systems, genetic testing, and digital health adoption. NATO is not a fertility policy bloc, but many NATO economies have resilient medical supply chains, advanced healthcare infrastructure, and defense-adjacent innovation ecosystems that can support secure data, diagnostics, and laboratory automation for male infertility care.

Key Country Insights in Male Infertility

The United States leads in advanced fertility services, genetic testing, fertility platforms, and employer-sponsored benefits, while Canada shows steady development through provincial funding models and specialist referral networks. Mexico benefits from cross-border fertility care and cost competitiveness, and Brazil remains a major Latin American fertility hub with strong private-sector capacity. The United Kingdom is shaped by HFEA oversight, Germany by strict embryo and reproductive laws, France by evolving bioethics policy, Russia by domestic capacity and supply-chain constraints, Italy by regulated ART demand, and Spain by its role as a European fertility destination.

China is expanding reproductive healthcare in response to demographic pressures, while India’s ART Regulation Act and Surrogacy Regulation Act are formalizing a large and rapidly developing sector. Japan and South Korea face some of the world’s lowest fertility rates, increasing policy attention on infertility treatment. Australia combines Medicare-supported care, high clinical quality, and strong patient education, making it a benchmark for integrated male and female fertility services.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-based differentiation by investing in standardized semen analysis, validated genetic and hormonal testing, and multidisciplinary care models that connect urologists, reproductive endocrinologists, embryologists, genetic counselors, and mental health professionals. Organizations should also address affordability, transparent pricing, and patient navigation because delayed diagnosis and fragmented referrals remain major barriers to treatment.

Commercial strategies should focus on clinically validated AI, laboratory quality assurance, secure data governance, and compliant marketing. Partnerships with employers, insurers, academic centers, and public health programs can broaden access. Organizations that build trust through medical evidence, culturally sensitive counseling, and measurable outcomes will be better positioned than those relying on convenience alone.

Research Methodology

This executive summary is grounded in secondary research from authoritative public health, clinical, regulatory, and scientific sources, including the World Health Organization, CDC ART reporting, national fertility regulators, peer-reviewed andrology literature, and recognized reproductive medicine guidelines. The analysis emphasizes verified epidemiological facts, regulatory patterns, technology adoption signals, and regional healthcare infrastructure rather than unsubstantiated market-size claims.

The methodology applies triangulation across clinical evidence, policy developments, reimbursement context, demographic indicators, and fertility service availability. Insights were structured to support visibility while maintaining medical accuracy, using industry-relevant keywords such as male infertility treatment, semen analysis, sperm quality, assisted reproductive technology, IVF, ICSI, fertility diagnostics, and AI in reproductive medicine.

Conclusion

Male infertility is moving from an underdiagnosed condition to a strategic priority within global reproductive healthcare. The market is supported by rising infertility awareness, standardized diagnostics, wider ART utilization, and growing acceptance of male-focused fertility evaluation. However, stigma, uneven reimbursement, and variable regulatory maturity continue to shape adoption across regions.

The next phase of progress will be defined by clinically credible innovation, not isolated technology claims. Organizations that combine validated diagnostics, AI-supported workflows, personalized treatment pathways, and accessible care models will be best placed to improve reproductive outcomes and build durable leadership in male infertility care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Male Infertility Market, by Treatment Type
7.1. Medications
7.1.1. Hormonal Therapy
7.1.2. Antibiotics
7.1.3. Antioxidants & Supplements
7.2. Surgical Treatments
7.2.1. Varicocelectomy
7.2.2. Vasectomy Reversal
7.2.3. Obstruction Removal
7.3. Assisted Reproductive Technology
7.3.1. Intrauterine Insemination
7.3.2. In Vitro Fertilization
7.3.3. Intracytoplasmic Sperm Injection
7.4. Lifestyle & Behavioral Interventions
8. Male Infertility Market, by Diagnosis Type
8.1. Semen Analysis
8.2. Sperm Function Tests
8.3. Hormonal Evaluation
8.3.1. Serum Testosterone
8.3.2. Follicle-Stimulating Hormone
8.3.3. Luteinizing Hormone
8.4. Genetic Testing
8.5. Testicular Biopsy
9. Male Infertility Market, by Cause Type
9.1. Pre-Testicular
9.2. Testicular
9.3. Post-Testicular
10. Male Infertility Market, by Sperm Defect Category
10.1. Oligozoospermia
10.2. Asthenozoospermia
10.3. Teratozoospermia
10.4. Azoospermia
10.4.1. Obstructive Azoospermia
10.4.2. Non-Obstructive Azoospermia
10.5. Combined Semen Abnormalities
11. Male Infertility Market, by Age Group
11.1. Less Than 30 Years
11.2. 30 Years To 40 Years
11.3. More Than 40 Years
12. Male Infertility Market, by End User
12.1. Fertility Clinics
12.2. Hospitals
12.3. Research & Academic Institutes
12.4. Diagnostic Laboratories
13. Asia-Pacific Male Infertility Market
14. Europe Male Infertility Market
15. North America Male Infertility Market
16. Latin America Male Infertility Market
17. Africa Male Infertility Market
18. Middle East Male Infertility Market
19. NATO Male Infertility Market
20. G7 Male Infertility Market
21. European Union Male Infertility Market
22. BRICS Male Infertility Market
23. ASEAN Male Infertility Market
24. GCC Male Infertility Market
25. China Male Infertility Market
26. United States Male Infertility Market
27. Japan Male Infertility Market
28. Germany Male Infertility Market
29. India Male Infertility Market
30. United Kingdom Male Infertility Market
31. France Male Infertility Market
32. Australia Male Infertility Market
33. Italy Male Infertility Market
34. South Korea Male Infertility Market
35. Canada Male Infertility Market
36. Russia Male Infertility Market
37. Brazil Male Infertility Market
38. Mexico Male Infertility Market
39. Spain Male Infertility Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. The Cooper Companies Inc
41.2. Merck KGaA
41.3. Ferring International Center S.A.
41.4. Thermo Fisher Scientific Inc
41.5. Vitrolife AB
41.6. Zydus Lifesciences Limited
41.7. Hamilton Thorne Ltd
41.8. Shady Grove Fertility
41.9. Bayer AG
41.10. Sun Pharmaceutical Industries Ltd
41.11. Andrology Solutions Ltd
41.12. Cadila Pharmaceuticals Ltd
41.13. Cook Medical LLC
41.14. Fairhaven Health LLC
41.15. FUJIFILM Irvine Scientific Inc
41.16. Give Legacy, Inc
41.17. Halotech DNA SL
41.18. Intas Pharmaceuticals Ltd
41.19. Laboratory Corporation of America Holdings
41.20. Lenus Pharma GesmbH
41.21. Mankind Pharma Ltd
41.22. Maze Laboratories
41.23. Novartis AG
41.24. Orthomol pharmazeutische GmbH
41.25. Pfizer Inc
41.26. SCSA Diagnostics Inc
41.27. Theramex HQ UK Ltd
41.28. Winfertility
List of Figures
FIGURE 1. GLOBAL MALE INFERTILITY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL MALE INFERTILITY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL MALE INFERTILITY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL MALE INFERTILITY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL MALE INFERTILITY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL MALE INFERTILITY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MALE INFERTILITY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL MALE INFERTILITY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MALE INFERTILITY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL MALE INFERTILITY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL MALE INFERTILITY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 25. GLOBAL MALE INFERTILITY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. EUROPE MALE INFERTILITY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. EUROPE MALE INFERTILITY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. NORTH AMERICA MALE INFERTILITY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. NORTH AMERICA MALE INFERTILITY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. LATIN AMERICA MALE INFERTILITY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. LATIN AMERICA MALE INFERTILITY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA MALE INFERTILITY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA MALE INFERTILITY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. MIDDLE EAST MALE INFERTILITY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. MIDDLE EAST MALE INFERTILITY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. NATO MALE INFERTILITY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. NATO MALE INFERTILITY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. G7 MALE INFERTILITY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. G7 MALE INFERTILITY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION MALE INFERTILITY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION MALE INFERTILITY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. BRICS MALE INFERTILITY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. BRICS MALE INFERTILITY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. ASEAN MALE INFERTILITY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. ASEAN MALE INFERTILITY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. GCC MALE INFERTILITY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. GCC MALE INFERTILITY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. CHINA MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. UNITED STATES MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. JAPAN MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. GERMANY MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. INDIA MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. FRANCE MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. AUSTRALIA MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. ITALY MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. SOUTH KOREA MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. CANADA MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. RUSSIA MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. BRAZIL MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. MEXICO MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SPAIN MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL MALE INFERTILITY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MALE INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MALE INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MALE INFERTILITY MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL MALE INFERTILITY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MEDICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MEDICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HORMONAL THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HORMONAL THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HORMONAL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ANTIOXIDANTS & SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ANTIOXIDANTS & SUPPLEMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ANTIOXIDANTS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SURGICAL TREATMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SURGICAL TREATMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SURGICAL TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL VARICOCELECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL VARICOCELECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL VARICOCELECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL VASECTOMY REVERSAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL VASECTOMY REVERSAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL VASECTOMY REVERSAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL OBSTRUCTION REMOVAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL OBSTRUCTION REMOVAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL OBSTRUCTION REMOVAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL INTRAUTERINE INSEMINATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL INTRAUTERINE INSEMINATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL INTRAUTERINE INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IN VITRO FERTILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IN VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IN VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL INTRACYTOPLASMIC SPERM INJECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL INTRACYTOPLASMIC SPERM INJECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL INTRACYTOPLASMIC SPERM INJECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL LIFESTYLE & BEHAVIORAL INTERVENTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL LIFESTYLE & BEHAVIORAL INTERVENTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL LIFESTYLE & BEHAVIORAL INTERVENTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL SEMEN ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL SEMEN ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL SEMEN ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL SPERM FUNCTION TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SPERM FUNCTION TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SPERM FUNCTION TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HORMONAL EVALUATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HORMONAL EVALUATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HORMONAL EVALUATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL SERUM TESTOSTERONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL SERUM TESTOSTERONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL SERUM TESTOSTERONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL FOLLICLE-STIMULATING HORMONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL FOLLICLE-STIMULATING HORMONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL FOLLICLE-STIMULATING HORMONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL LUTEINIZING HORMONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL LUTEINIZING HORMONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL LUTEINIZING HORMONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL TESTICULAR BIOPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL TESTICULAR BIOPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL TESTICULAR BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PRE-TESTICULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PRE-TESTICULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PRE-TESTICULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL TESTICULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL TESTICULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL TESTICULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL POST-TESTICULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL POST-TESTICULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL POST-TESTICULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL OLIGOZOOSPERMIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL OLIGOZOOSPERMIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL OLIGOZOOSPERMIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ASTHENOZOOSPERMIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ASTHENOZOOSPERMIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ASTHENOZOOSPERMIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL TERATOZOOSPERMIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL TERATOZOOSPERMIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL TERATOZOOSPERMIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL AZOOSPERMIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL AZOOSPERMIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL AZOOSPERMIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL OBSTRUCTIVE AZOOSPERMIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL OBSTRUCTIVE AZOOSPERMIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL OBSTRUCTIVE AZOOSPERMIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL NON-OBSTRUCTIVE AZOOSPERMIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL NON-OBSTRUCTIVE AZOOSPERMIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL NON-OBSTRUCTIVE AZOOSPERMIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL COMBINED SEMEN ABNORMALITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL COMBINED SEMEN ABNORMALITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL COMBINED SEMEN ABNORMALITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL LESS THAN 30 YEARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL LESS THAN 30 YEARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL LESS THAN 30 YEARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL 30 YEARS TO 40 YEARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL 30 YEARS TO 40 YEARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL 30 YEARS TO 40 YEARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL MORE THAN 40 YEARS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL MORE THAN 40 YEARS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL MORE THAN 40 YEARS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL FERTILITY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL FERTILITY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL FERTILITY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. EUROPE MALE INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 142. EUROPE MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 143. EUROPE MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 144. EUROPE MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 145. EUROPE MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 146. EUROPE MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 147. EUROPE MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 149. EUROPE MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 150. EUROPE MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 151. EUROPE MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA MALE INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA MALE INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. AFRICA MALE INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 177. AFRICA MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 178. AFRICA MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 179. AFRICA MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 180. AFRICA MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 181. AFRICA MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 182. AFRICA MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 183. AFRICA MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 184. AFRICA MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 185. AFRICA MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 186. AFRICA MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 187. AFRICA MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST MALE INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. NATO MALE INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. NATO MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 202. NATO MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 203. NATO MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 204. NATO MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 205. NATO MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 206. NATO MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 207. NATO MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 208. NATO MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 209. NATO MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 210. NATO MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 211. NATO MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. G7 MALE INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 213. G7 MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 214. G7 MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 215. G7 MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 216. G7 MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 217. G7 MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 218. G7 MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 219. G7 MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 220. G7 MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 221. G7 MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 222. G7 MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 223. G7 MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION MALE INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. BRICS MALE INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 237. BRICS MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 238. BRICS MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 239. BRICS MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 240. BRICS MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 241. BRICS MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 242. BRICS MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 243. BRICS MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 244. BRICS MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 245. BRICS MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 246. BRICS MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 247. BRICS MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. ASEAN MALE INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 249. ASEAN MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 250. ASEAN MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 251. ASEAN MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 252. ASEAN MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 253. ASEAN MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 254. ASEAN MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 255. ASEAN MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 256. ASEAN MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 257. ASEAN MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 258. ASEAN MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 259. ASEAN MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. GCC MALE INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 261. GCC MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 262. GCC MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 263. GCC MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 264. GCC MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 265. GCC MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 266. GCC MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 267. GCC MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 268. GCC MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 269. GCC MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 270. GCC MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 271. GCC MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 272. CHINA MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 273. CHINA MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 274. CHINA MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 275. CHINA MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 276. CHINA MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 277. CHINA MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 278. CHINA MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 279. CHINA MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 280. CHINA MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 281. CHINA MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 282. CHINA MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 283. CHINA MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 292. UNITED STATES MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 293. UNITED STATES MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 294. UNITED STATES MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 295. UNITED STATES MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 296. JAPAN MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 297. JAPAN MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 298. JAPAN MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 299. JAPAN MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 300. JAPAN MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 301. JAPAN MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 302. JAPAN MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 303. JAPAN MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 304. JAPAN MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 305. JAPAN MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 306. JAPAN MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 307. JAPAN MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 308. GERMANY MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 309. GERMANY MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 310. GERMANY MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 311. GERMANY MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 312. GERMANY MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 313. GERMANY MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 314. GERMANY MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 315. GERMANY MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 316. GERMANY MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 317. GERMANY MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 318. GERMANY MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 319. GERMANY MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 320. INDIA MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 321. INDIA MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 322. INDIA MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 323. INDIA MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 324. INDIA MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 325. INDIA MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 326. INDIA MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 327. INDIA MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 328. INDIA MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 329. INDIA MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 330. INDIA MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 331. INDIA MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 332. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 333. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 334. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 335. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 336. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 337. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 338. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 339. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 340. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 341. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 342. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 343. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 344. FRANCE MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 345. FRANCE MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 346. FRANCE MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 347. FRANCE MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 348. FRANCE MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 349. FRANCE MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 350. FRANCE MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 351. FRANCE MALE INFERTILITY MARKET SIZE, BY CAUSE TYPE, 2018-2032 (USD MILLION)
TABLE 352. FRANCE MALE INFERTILITY MARKET SIZE, BY SPERM DEFECT CATEGORY, 2018-2032 (USD MILLION)
TABLE 353. FRANCE MALE INFERTILITY MARKET SIZE, BY AZOOSPERMIA, 2018-2032 (USD MILLION)
TABLE 354. FRANCE MALE INFERTILITY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 355. FRANCE MALE INFERTILITY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 356. AUSTRALIA MALE INFERTILITY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 357. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 358. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 359. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
TABLE 360. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 361. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2032 (USD MILLION)
TABLE 362. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY HORMONAL EVALUATION, 2018-2032 (USD MILLION)
TABLE 363. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY CAUSE T

Companies Mentioned

The companies featured in this Male Infertility market report include:
  • The Cooper Companies Inc
  • Merck KGaA
  • Ferring International Center S.A.
  • Thermo Fisher Scientific Inc
  • Vitrolife AB
  • Zydus Lifesciences Limited
  • Hamilton Thorne Ltd
  • Shady Grove Fertility
  • Bayer AG
  • Sun Pharmaceutical Industries Ltd
  • Andrology Solutions Ltd
  • Cadila Pharmaceuticals Ltd
  • Cook Medical LLC
  • Fairhaven Health LLC
  • FUJIFILM Irvine Scientific Inc
  • Give Legacy, Inc
  • Halotech DNA SL
  • Intas Pharmaceuticals Ltd
  • Laboratory Corporation of America Holdings
  • Lenus Pharma GesmbH
  • Mankind Pharma Ltd
  • Maze Laboratories
  • Novartis AG
  • Orthomol pharmazeutische GmbH
  • Pfizer Inc
  • SCSA Diagnostics Inc
  • Theramex HQ UK Ltd
  • Winfertility

Table Information

Report AttributeDetails
No. of Pages182
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.07 Billion
Forecasted Market Value ( USD ) by 2032 $ 7.41 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Male Infertility - Global Strategic Business Report - Product Image

Male Infertility - Global Strategic Business Report

  • Report
  • 278 Pages
  • Global
From
Male Infertility Market Report by Test Type, Treatment, Distribution Channel, End User, and Region 2026-2034 - Product Image

Male Infertility Market Report by Test Type, Treatment, Distribution Channel, End User, and Region 2026-2034

  • Report
  • 147 Pages
  • Global
From
Male Infertility Market Report 2026 - Product Image

Male Infertility Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Male Infertility Global Market Opportunities and Strategies to 2034 - Product Image

Male Infertility Global Market Opportunities and Strategies to 2034

  • Report
  • 332 Pages
  • Global
From
Male Infertility Epidemiology Forecast 2025-2034 - Product Image

Male Infertility Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From

About the Mens Health Market

Mens Health is a branch of healthcare services that focuses on the health and well-being of men. It encompasses a wide range of topics, including physical health, mental health, and lifestyle. It also includes preventive care, such as screenings and vaccinations, as well as diagnosis and treatment of diseases and conditions. Mens Health services are tailored to the unique needs of men, including those related to gender, age, and lifestyle. Mens Health services are provided by a variety of healthcare providers, including primary care physicians, specialists, and mental health professionals. These providers work together to provide comprehensive care for men. They may also refer men to other healthcare providers, such as nutritionists, physical therapists, and counselors. Some companies in the Mens Health market include WebMD, Healthline, and Men's Health Magazine. Other companies include Men's Health Network, Men's Health Forum, and Men's Health Center. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.